ETRA vs ACRS
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ETRA · ELECTRA THERAPEUTICS INC$8.11 ▼ 9.28%
ACRS · Aclaris Therapeutics$3.44 ▼ 1.71%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ETRA -38.8%
- ACRS -37.5%
Head to head
| Metric | ETRA | ACRS |
|---|---|---|
| Price | $8.11 | $3.44 |
| Change today | ▼ 9.28% | ▼ 1.71% |
| Market cap | $509.85M | $545.63M |
| Return, 3 months | – | -45.5% |
| Return, year to date | – | +14.3% |
| Return, 1 year | – | +37.1% |
| P/E (TTM) | – | – |
| P/B | 1.3 | 3.3 |
| P/E percentile vs own 5y | 71st | 43rd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | -55.1% |
| Net profit growth (YoY) | -150.0% | -26.7% |
| Gross margin | – | 5.8% |
| Operating margin | – | -1,412.4% |
| Net margin | – | -1,244.1% |
| Return on equity | – | -55.5% |
| Analyst target vs. price | +302.8% | +240.4% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 43 | 39 |
| 30-day volatility | 96.0% | 72.8% |
| Max drawdown, 1 year | -47.5% | -49.8% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ACRS is the largest of the group by market value.
- ACRS has been the calmest stock over the last 30 days.